These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17334352)

  • 1. Immunoglobulin VH gene analysis in gastric MALT lymphomas.
    Sakuma H; Nakamura T; Uemura N; Chiba T; Sugiyama T; Asaka M; Akamatsu T; Ueda R; Eimoto T; Goto H; Nakamura S; Inagaki H
    Mod Pathol; 2007 Apr; 20(4):460-6. PubMed ID: 17334352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion.
    Inagaki H; Nakamura T; Li C; Sugiyama T; Asaka M; Kodaira J; Iwano M; Chiba T; Okazaki K; Kato A; Ueda R; Eimoto T; Okamoto S; Sasaki N; Uemura N; Akamatsu T; Miyabayashi H; Kawamura Y; Goto H; Niwa Y; Yokoi T; Seto M; Nakamura S
    Am J Surg Pathol; 2004 Dec; 28(12):1560-7. PubMed ID: 15577674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
    Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
    Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yokoi T; Suzuki H; Ohashi K; Seto M
    Jpn J Cancer Res; 2002 Jun; 93(6):677-84. PubMed ID: 12079516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
    Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
    Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response.
    Liu TY; Chen SU; Kuo SH; Cheng AL; Lin CW
    Mod Pathol; 2010 Nov; 23(11):1507-17. PubMed ID: 20802470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.
    Dong G; Liu C; Ye H; Gong L; Zheng J; Li M; Huang X; Huang X; Huang Y; Shi Y; Yin W; Gao Z
    Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy.
    Alpen B; Thiede C; Wündisch T; Bayerdörffer E; Stolte M; Neubauer A
    Clin Lymphoma; 2001 Sep; 2(2):103-8. PubMed ID: 11707850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of API2-MALT1 fusion, trisomies, and immunoglobulin VH genes in pulmonary mucosa-associated lymphoid tissue lymphoma.
    Xia H; Nakayama T; Sakuma H; Yamada S; Sato F; Takino H; Okabe M; Fujiyoshi Y; Hattori H; Inagaki H
    Hum Pathol; 2011 Sep; 42(9):1297-304. PubMed ID: 21396678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs.
    Iwano M; Okazaki K; Uchida K; Nakase H; Ohana M; Matsushima Y; Inagaki H; Chiba T
    J Gastroenterol; 2004 Aug; 39(8):739-46. PubMed ID: 15338367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.
    Liu H; Ruskon-Fourmestraux A; Lavergne-Slove A; Ye H; Molina T; Bouhnik Y; Hamoudi RA; Diss TC; Dogan A; Megraud F; Rambaud JC; Du MQ; Isaacson PG
    Lancet; 2001 Jan; 357(9249):39-40. PubMed ID: 11197361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API2-MALT1 fusion gene in colorectal lymphoma.
    Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
    Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
    Nakamura T; Inagaki H; Seto M; Nakamura S
    J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma.
    Fujimori K; Shimodaira S; Akamatsu T; Furihata K; Katsuyama T; Hosaka S
    Br J Cancer; 2005 Jan; 92(2):312-9. PubMed ID: 15655559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.